Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00642876 · ClinicalTrials.gov registry record · NA
PRESTIGE® Cervical Disc Study
A NA study, sponsored by Medtronic Spinal and Biologics.
- Completed
- Registry status
- NA
- Development phase
- 541
- Enrollment target
NCT00642876 is a NA study that has completed, run by Medtronic Spinal and Biologics. The registered enrollment target is 541 participants.
The verdict
NCT00642876, a NA study, has completed, sponsored by Medtronic Spinal and Biologics.
- COMPLETED
- Registry status
- NA
- Development phase
- 541 participants
- Enrollment target
Study Summary
The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a PMA application for the ACD.
Interventions
- DEVICE Allograft Fusion and ATLANTIS™ Cervical Plate System
- DEVICE PRESTIGE® Cervical Disc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 541 participants |
| Start Date | 2002-10 |
| Est. Completion | 2013-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00642876
The ClinicalTrials.gov registry entry for NCT00642876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 541 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Allograft Fusion and ATLANTIS™ Cervical Plate System is the first listed.
NCT00642876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00642876 about?
NCT00642876 is a clinical study titled "PRESTIGE® Cervical Disc Study". The purpose of this clinical investigation is to evaluate the safety and effectiveness of the ACD in the single level surgical treatment of patients with symptomatic cervical degenerative disc disease. The primary follow-up information obtained from this clinical investigation are used to support a ...
What is the current status of trial NCT00642876?
This trial is currently completed. It is a NA study. The enrollment target is 541 participants. The study started on 2002-10. Estimated completion is 2013-05.
What interventions are being tested in trial NCT00642876?
The interventions under investigation include: Allograft Fusion and ATLANTIS™ Cervical Plate System (DEVICE), PRESTIGE® Cervical Disc (DEVICE).
Who is sponsoring clinical trial NCT00642876?
This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.